BOARD OF DIRECTORS
The Board of Directors serves as advisors to guide the direction and growth of the CCTMC.
We are honored to have these distinguished industry and academic leaders serve our organization.
Carlo Cristobal, Ph.D.
Project Leader,
Boston Consulting Group
Carlo is currently a Project Leader at Boston Consulting Group, focusing in Biopharma sector. He got his Ph.D. in Integrative Molecular and Biomedical Sciences at Baylor College of Medicine. During his Ph.D. he collaborated with leading companies in biopharma, biotech, and private equity and gained experience in brand strategy, corporate transformation, product launch & commercialization, due diligence, and data analytics. Carlo served as the President of CCTMC in 2021-2022.
Red is a machine learning engineer adept at designing, developing, and deploying machine learning systems with a focus on system design, scalability, and stability. He received a Ph.D. in molecular physiology and biophysics from Baylor College of Medicine where he used carbon nanotechnology to develop a new treatment for autoimmune diseases. During graduate school, Red served as the President of Baylor’s consulting club. Realizing the tremendous interest in consulting within Houston and the untapped potential of collaborative efforts among the many Texas Medical Center institutions, he brought together the community by establishing the Consulting Club at the Texas Medical Center and served as its Founding President.
Red Huq, Ph.D.
Principle Machine Learning Engineer,
Nielsen
​
CCTMC Founding President
Oscar Truong, Ph.D.
Consultant,
Bain & Company
Oscar is a consultant at Bain, working in healthcare private equity. He received a Ph.D. in molecular virology and microbiology from Baylor College of Medicine where he focused on engineering resistance against HIV utilizing membrane anchored viral inhibitors. Oscar served as the Senior Vice President for CCTMC in 2022-2023.